Clinical Trial Update: Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a vaccine therapy in combination with celecoxib for metastatic nasopharyngeal carcinoma; this entry provides an update on the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nasopharyngeal Carcinoma

Drugs mentioned

• Celecoxib (Celecoxib)
• Vaccine therapy

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN